Evaluation and diagnostic testing of erectile dysfunction in the era of phosphodiesterase type 5 inhibitors. Asian J Androl 2007 Jan;9(1):3-7
Date
12/26/2006Pubmed ID
17187154DOI
10.1111/j.1745-7262.2007.00232.xScopus ID
2-s2.0-33845988052 (requires institutional sign-in at Scopus site) 4 CitationsAbstract
The diagnosis and treatment of erectile dysfunction has changed dramatically since the availability of safe and effective oral therapies. Unfortunately, not all men can be adequately treated in this way, and might require more invasive testing to diagnose and treat the specific cause of their dysfunction. This review looks at the tests and strategies available for men who cannot be treated by oral therapy alone.
Author List
Jacobsohn K, Wang RAuthor
Kenneth Jacobsohn MD Professor in the Urologic Surgery department at Medical College of WisconsinMESH terms used to index this publication - Major topics in bold
3',5'-Cyclic-GMP PhosphodiesterasesAdministration, Oral
Angiography
Blood Flow Velocity
Cyclic Nucleotide Phosphodiesterases, Type 5
Enzyme Inhibitors
Erectile Dysfunction
Humans
Injections
Male
Penis
Phosphodiesterase Inhibitors
Vasodilator Agents
